Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for May 28th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 28th:

North American Construction Group Ltd. (NOA - Free Report) : This heavy construction and mining services provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 6.9% over the last 60 days.

North American Construction has a price-to-earnings ratio (P/E) of 8.32, compared with 10.60 for the industry. The company possesses a Value Score of A.

Xcel Brands, Inc. (XELB - Free Report) : This consumer products company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 26.9% over the last 60 days.

Xcel has a price-to-earnings ratio (P/E) of 3.25, compared with 13.30 for the industry. The company possesses a Value Score of A.

Cummins Inc. (CMI - Free Report) : This diesel and natural gas engines manufacturer has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 4.7% over the last 60 days.

Cummins has a price-to-earnings ratio (P/E) of 9.88, compared with 10.00 for the industry. The company possesses a Value Score of B.

Cummins Inc. PE Ratio (TTM)

Cummins Inc. PE Ratio (TTM)

Cummins Inc. pe-ratio-ttm | Cummins Inc. Quote

Perion Network Ltd. (PERI - Free Report) : This technology company that delivers advertising solutions to brands, agencies and publishers has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 18.8% over the last 60 days.

Perion Network has a price-to-earnings ratio (P/E) of 8.37 compared with 17.80 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>